Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06276725 · ClinicalTrials.gov registry record · NA
Writing Wrongs: Expressive Writing for Microaggressions
A NA study of Posttraumatic Stress Disorder and Discriminatory Stress, sponsored by Auburn University.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT06276725 is a NA study of Posttraumatic Stress Disorder and Discriminatory Stress that has completed, run by Auburn University. The registered enrollment target is 70 participants, below the 111-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06276725, a NA study of Posttraumatic Stress Disorder and Discriminatory Stress, has completed, sponsored by Auburn University.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
Racial and ethnic based stressors, such as microaggressions, are pervasive, distressing, and result in lasting negative repercussions for minoritized students at predominantly white institutions (PWIs). These racial and ethnic based stressors are experienced in addition to the universally experienced stressors of higher education. Negative repercussions of microaggressions include increased drop out or transfer rates, distress, fatigue resulting in decreased academic performance, and depression and posttraumatic stress symptoms. Expressive writing (EW) may be a scalable intervention for addressing the negative repercussions resulting from microaggressions experienced by minoritized students at PWIs. Previous research suggests that EW for stressful life events results in benefits such as reduced depression and posttraumatic stress symptoms, improved coping strategies, and reduced activity restriction. Despite such benefits, EW was not designed to specifically address microaggressions in a minoritized student population. Informed by the ADAPT-ITT model, our research group conducted a pilot study with similar procedures. This pilot study demonstrated the acceptability of an adapted version of the EW intervention titled Writing Wrongs (WW), as well as recommended future modifications for WW. In the current study we aim to conduct a randomized-controlled trial to establish the efficacy of WW in alleviating clinical symptoms. We hypothesize that WW will improve symptoms of racial and discriminatory trauma and symptoms of depression, anxiety, and posttraumatic stress over time and compared to an assessment-only condition. We will conduct exploratory analyses to examine short-term changes in affect within and across sessions and across conditions. We will recruit minoritized students enrolled at a PWI. Participants will complete a pre-intervention assessment prior to being randomized into the two conditions. Participants in the intervention condition will engage in three se
Conditions Studied
Interventions
- BEHAVIORAL Writing Wrongs
Study Locations (1)
Alabama
- Auburn University - Auburn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2024-03-18 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06276725
The ClinicalTrials.gov registry entry for NCT06276725 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 111-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (37% lower). The listed sponsor is Auburn University, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Posttraumatic Stress Disorder appearing as the primary indexed condition, and to 1 intervention - of which Writing Wrongs is the first listed.
NCT06276725 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT06276725 about?
NCT06276725 is a clinical study titled "Writing Wrongs: Expressive Writing for Microaggressions". Racial and ethnic based stressors, such as microaggressions, are pervasive, distressing, and result in lasting negative repercussions for minoritized students at predominantly white institutions (PWIs). These racial and ethnic based stressors are experienced in addition to the universally experience...
What is the current status of trial NCT06276725?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2024-03-18. Estimated completion is 2024-12-31.
What conditions does trial NCT06276725 study?
This clinical trial studies the following conditions: Posttraumatic Stress Disorder, Discriminatory Stress, Microaggression.
What interventions are being tested in trial NCT06276725?
The interventions under investigation include: Writing Wrongs (BEHAVIORAL).
Who is sponsoring clinical trial NCT06276725?
This trial is sponsored by Auburn University, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06276725 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Posttraumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes
RECRUITING · NA
-
Positive Processes and Transition to Health (PATH)
RECRUITING · NA
-
Impact of Cognitive Behavioral Therapy on PTSD-CVD Link
RECRUITING · NA
-
A Mechanistic Trial of the Neurobiology of Extinction Learning and Intraparietal Sulcus Stimulation
RECRUITING · NA
-
Trauma Screening/Referral and Interpersonal Violence Prevention for Women with Substance Use Disorders
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.